Target intelligence / Profile preview

Cytochrome c oxidase binuclear heme a3-CuB center (COX BNC)

Target
COX BNC
Molecular classification
Enzyme, Oxidoreductase, Metalloprotein, Mitochondrial respiratory chain complex
01

Overview

The Cytochrome c oxidase binuclear heme a3-CuB center is the primary catalytic site of Complex IV, the final enzyme in the mitochondrial respiratory electron transport chain (Source: Wikipedia, Cytochrome c oxidase). This site consists of a high-spin heme a3 iron and a copper ion (CuB), which together facilitate the four-electron reduction of molecular oxygen to water (Source: J Biol Chem. 2012;287(16):13448-13455). This process is vital for aerobic life, as it drives the proton gradient necessary for ATP synthesis (Source: UniProt P00395). The binuclear center is the specific target of lethal inhibitors such as cyanide, carbon monoxide, and hydrogen sulfide, which bind to the heme a3 iron and block oxygen binding, resulting in immediate cessation of cellular respiration (Source: StatPearls, Cyanide Toxicity). Clinically, dysfunction of this center is associated with mitochondrial encephalomyopathies like Leigh syndrome and is a focal point in the study of neurodegenerative diseases and ischemia-reperfusion injury (Source: NIH, Genetics Home Reference). Because of its central role in energy metabolism, the site is a critical marker for metabolic health and a key subject in toxicological research.

Other names
Heme a3-CuB centerBinuclear center of cytochrome c oxidaseComplex IV active siteCytochrome aa3 binuclear centerOxygen reduction site of Complex IV
02

Mechanism of action

Inhibitors bind to the heme a3 iron or the CuB center, competitively or non-competitively blocking the binding and reduction of molecular oxygen, thereby halting the electron transport chain and ATP production (Source: PubChem, Cyanide; StatPearls, Carbon Monoxide Toxicity).

03

Biological functions

Cellular respirationOxygen reductionProton translocationATP synthesis support
04

Disease associations

Mitochondrial encephalomyopathyLeigh syndromeCyanide poisoningCarbon monoxide poisoningNeurodegenerative disease
05

Safety considerations

Inhibition leads to rapid cellular hypoxia and metabolic acidosis (Source: StatPearls, Cyanide Toxicity)High risk of lethality with potent inhibitorsDifficulty in selective targeting without affecting systemic energy metabolism
06

Interacting drugs

Cyanide

4 more in the full profile.

07

Biomarkers

Blood lactate levelsCytochrome c oxidase activityVenous oxygen saturationMitochondrial DNA sequencing

Beyond the preview

Go deeper on Cytochrome c oxidase binuclear heme a3-CuB center (COX BNC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c oxidase binuclear heme a3-CuB center (COX BNC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call